Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

NCT00486460 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

OTHER_GOV

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Gemcitabine
DRUG: Curcumin
DRUG: Celebrex

Sponsor

Tel-Aviv Sourasky Medical Center